Back to PRICE T ROWE ASSOCIATES INC /MD/ PRICE T ROWE ASSOCIATES INC /MD/

ABCLABCL
6 quarters

Position history for PRICE T ROWE ASSOCIATES INC /MD/PRICE T ROWE ASSOCIATES INC /MD/'s holdings in ABCELLERA BIOLOGICS INC

PRICE T ROWE ASSOCIATES INC /MD/ holds 1.6M shares of ABCL (ABCELLERA BIOLOGICS INC), worth $12.5M as of 2026-Q2. This is a new position. ABCL represents 0.0% of PRICE T ROWE ASSOCIATES INC /MD/'s portfolio.

Current Value

$12.5M

Current Shares

1.6M

Total Value Change

+$12.3M

Total Shares Change

+1.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
1.6M
-
$12.5M0.0%$7.85
39
2023-Q2
Exited
0
-100.0%
$00.0%$6.58
0
2023-Q1
Increased
39,916
+11.0%
$301,0000.0%$7.42
18
2022-Q4
Increased
35,963
+6.7%
$364,0000.0%$10.13
25
2022-Q3
Increased
33,714
+70.6%
$334,0000.0%$9.85
35
2022-Q2
New
19,759
-
$210,0000.0%$10.11
35

Other major holders of ABCL: VIKING GLOBAL INVESTORS LP, BAKER BROS. ADVISORS LP, Capital World Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used